SOLACI-CACI 2024 – Day 1 Presentations

Discover the highlights of the first day of activities of SOLACICACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. 

  • Dr. Mauricio Cohen (USA) – “How to start a CHIP program?”
  • Dr. Augusto Pichard (USA) – “Current Strategies for Percutaneous Treatment of SVG Disease in ACS”
  • Dra. Alaide Chieffo (ITA) – “Analysis of post-stent coronary dissections, when we should treat it”
  • Dr. George Dangas (USA) – “Is there a role for thrombus aspiration in PCI?”
  • Dr. Roxana Mehran (USA) – “Anti-platelet treatment in AMI and Inflammation”
  • Dr. Daniel Berrocal (ARG) – “PCI in Patient with Symptomatic Chronic Coronary Syndrome”
  • Dr. Daniel Aguirre (CHL) – “Required Credentials for an Interventional Cardiologist to Intervene in Adult Congenital Heart Disease”
  • Dra. Tieta Albanez (BRA) – “Current Status of LMCA PCI: Contributions From Clinical Studies”
  • Dr. Mario Araya (CHL) – “Dissections: what we should and should not leave”
  • Dr. Ricardo Costa (BRA) – “Understand the concepts, techniques, and devices to achieve optimal vessel preparation for the perfect DEB outcome-DEB technology in de novo coronary lesions”
  • Dr. Juan Ignacio Damonte (ARG) – “Barriers and oportunities in the decision -making process for a Cardiology subespeciality”
  • Dr. Anibal Damonte (ARG) – “LAAO: What´ s the best management of peridevice leak?”
  • Dr. George Dangas (USA) – “TAVR and Coronary artery disease”
  • Dr. Diego Guzzanti (ARG) – “Deep Vein Thrombosis: Treatment. Pharmacoinvasive Treatment and Percutaneous Thrombectomy”
  • Dr. Pablo Mascolo (ARG) – “When do we consider a lesion to be non-obstructive: by angiography or angioCT”
  • Dr. Ricardo Lluberas (UY) – “Multivessel Disease: Is Complete Revascularization Necessary in Fragile Adult Patients?”
  • Dr. José Martín Rabellino (ARG) – “Surgery for TAVI failure: what do we know about device explantation?”
  • Dr. Evandro Martins (BRA) – “The post-CABG CTO challenge”
  • Dr. Matías Rodríguez Granillo (ARG) – “Patient with Coronary Disease and Diabetes”
  • Dr. Sebastián Mrad (ARG) – “Mentoring as a Tool to Optimize Decision-Making During a Medical Career”

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...